Adagene Inc. (ADAG)
NASDAQ: ADAG · Real-Time Price · USD
3.720
+0.030 (0.81%)
Mar 20, 2026, 10:56 AM EDT - Market open
Adagene Market Cap
Adagene has a market cap or net worth of $175.33 million as of March 20, 2026. Its market cap has increased by 93.19% in one year.
Market Cap
175.33M
Enterprise Value
117.94M
1-Year Change
93.19%
Ranking
Category
Stock Price
$3.72
Market Cap Chart
Since the IPO on February 9, 2021, Adagene's market cap has decreased from $804.22M to $175.33M, a decrease of -78.20%. That is a compound annual growth rate of -25.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 173.91M | 95.24% |
| Dec 31, 2025 | 89.08M | 1.11% |
| Dec 31, 2024 | 88.10M | 4.06% |
| Dec 29, 2023 | 84.66M | 47.15% |
| Dec 30, 2022 | 57.54M | -83.64% |
| Dec 31, 2021 | 351.59M | -56.28% |
| Feb 9, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galectin Therapeutics | 180.52M |
| Sutro Biopharma | 179.81M |
| Protalix BioTherapeutics | 179.34M |
| Acumen Pharmaceuticals | 176.87M |
| Molecular Partners AG | 175.46M |
| Tenaya Therapeutics | 174.40M |
| Cartesian Therapeutics | 174.16M |
| Canton Strategic Holdings | 174.13M |